Why Poseida Therapeutics Is Trading Higher By Around 100%, Here Are 75 Stocks Moving In Wednesday''s Mid-Day Session
Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT ) shares jumped 167% to $1.72 after dropping 13% on Tuesday. Kaspien Holdings Inc. (NASDAQ: KSPN ) gained 112.4% to $5.48. Eargo, Inc. (NASDAQ: EAR ) shares climbed 102.8% to $1.42. The company is scheduled to report Q2 earnings on Monday, August 8. Poseida Therapeutics, Inc. (NASDAQ: PSTX ) shares jumped 99.6% to $4.85 as the company entered into a strategic collaboration and license agreement with Roche Holdings AG, focused on developing allogeneic CAR-T therapies directed to hematologic malignancies. Applied DNA Sciences, Inc. (NASDAQ: APDN ) climbed 75.7% to $4.92 on continued strength after the company initiated analytical validation of a Company-developed, PCR-based monkeypox virus test that is specific for the genetic signature of the monkeypox virus. Kintara Therapeutics, Inc. (NASDAQ: KTRA ) gained 70% to $0.3013 after the company entered into an equity purchase agreement with Lincoln Park Capital for up to $20 million. Ping Identity Holding Corp. (NYSE: PING ) shares climbed 59.8% to $27.92 after the company announced it will be acquired by Thoma Bravo for $28.50 per share in cash.
Why Poseida Therapeutics Is Trading Higher By Around 100%, Here Are 75 Stocks Moving In Wednesday''s Mid-Day Session
Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT ) shares jumped 167% to $1.72 after dropping 13% on Tuesday. Kaspien Holdings Inc. (NASDAQ: KSPN ) gained 112.4% to $5.48. Eargo, Inc. (NASDAQ: EAR ) shares climbed 102.8% to $1.42. The company is scheduled to report Q2 earnings on Monday, August 8. Poseida Therapeutics, Inc. (NASDAQ: PSTX ) shares jumped 99.6% to $4.85 as the company entered into a strategic collaboration and license agreement with Roche Holdings AG, focused on developing allogeneic CAR-T therapies directed to hematologic malignancies. Applied DNA Sciences, Inc. (NASDAQ: APDN ) climbed 75.7% to $4.92 on continued strength after the company initiated analytical validation of a Company-developed, PCR-based monkeypox virus test that is specific for the genetic signature of the monkeypox virus. Kintara Therapeutics, Inc. (NASDAQ: KTRA ) gained 70% to $0.3013 after the company entered into an equity purchase agreement with Lincoln Park Capital for up to $20 million. Ping Identity Holding Corp. (NYSE: PING ) shares climbed 59.8% to $27.92 after the company announced it will be acquired by Thoma Bravo for $28.50 per share in cash.